Disruption in the expression and immunolocalisation of steroid receptors and steroidogenic enzymes in letrozole-induced polycystic ovaries in rat

Reproduction, Fertility and Development

Volumn 21, Issue 7, 2009, Pages 827-839

  Zurvarra, Francisco M ^a   Salvetti, Natalia R ^a,b   Mason, J Ian ^c   Velazquez, Melisa M L ^a   Alfaro, Natalia S ^a   Ortega, Hugo H ^a,b  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

hydroxysteroid dehydrogenase; 3 ; Aromatase; Polycystic ovarian syndrome; StAR; Steroid receptors

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN RECEPTOR; AROMATASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FOLLITROPIN; LETROZOLE; LUTEINIZING HORMONE; PROGESTERONE; PROGESTERONE RECEPTOR; STEROID RECEPTOR; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIESTRUS; ESTRADIOL BLOOD LEVEL; EXPERIMENTAL MODEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; IMMUNOLOCALIZATION; LUTEINIZING HORMONE BLOOD LEVEL; NONHUMAN; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PROESTRUS; PROGESTERONE BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TESTOSTERONE BLOOD LEVEL; TISSUE DISTRIBUTION;

3-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; AROMATASE; BLOTTING, WESTERN; DIESTRUS; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; FOLLICLE STIMULATING HORMONE; IMMUNOHISTOCHEMISTRY; LUTEINIZING HORMONE; NITRILES; OVARY; PHOSPHOPROTEINS; POLYCYSTIC OVARY SYNDROME; PROESTRUS; PROGESTERONE; RATS; RATS, WISTAR; RECEPTORS, ANDROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, STEROID; TESTOSTERONE; TRIAZOLES;

RATTUS;

EID: 69249116992     PISSN: 10313613     EISSN: None     Source Type: Journal    
DOI: 10.1071/RD09026     Document Type: Article

References (67)

1. Abbott, D. H., Dumesic, D. A., and Franks, S. (2002). Developmental origin of polycystic ovary syndrome - a hypothesis. J. Endocrinol. 174, 1-5. doi:10.1677/JOE.0.1740001
2. Andreani, C. L., Pierro, E., Lazzarin, N., Lanzone, A., Caruso, A., and Mancuso, S. (1996). Effect of follicular fluid on granulosa luteal cells from polycystic ovary. Hum. Reprod. 11, 2107-2113.
3. Bao, B., Kumar, N., Karp, R. M., Garverick, H. A., and Sundaram, K. (2000). Estrogen receptor-beta expression in relation to the expression of luteinizing hormone receptor and cytochrome P450 enzymes in rat ovarian follicles. Biol. Reprod. 63, 1747-1755. doi:10.1095/BIOLREPROD63. 6.1747
4. Baravalle, C., Salvetti, N. R., Mira, G. A., Pezzone, N., and Ortega, H. H. (2006). Microscopic characterization of follicular structures in letrozoleinduced polycystic ovarian syndrome in the rat. Arch. Med. Res. 37, 830-839. doi:10.1016/J.ARCMED.2006.04.006
5. Beato, M., and Klug, J. (2000). Steroid hormone receptors: an update. Hum. Reprod. Update 6, 225-236. doi:10.1093/HUMUPD/6.3.225
6. Berisha, B., Pfaffl, M., and Schams, D. (2002). Expression of estrogen and progesterone receptors in the bovine ovary during estrous cycle and pregnancy. Endocrine 17, 207-214. doi:10.1385/ENDO:17:3:207
7. Bhatnagar,A. S. (2007).The discovery and mechanism of action of letrozole. Breast Cancer Res. Treat. 105(Suppl. 1), 7-17. doi:10.1007/S10549-007-9696-3
8. Blank, S. K., McCartney, C. R., and Marshall, J. C. (2006). The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum. Reprod. Update 12, 351-361. doi:10.1093/HUMUPD/DML017
9. Bukovsky, A., Ayala, M. E., Dominguez, R., Keenan, J. A., Wimalasena, J., Elder, R. F., and Caudle, M. R. (2002). Changes of ovarian interstitial cell hormone receptors and behavior of resident mesenchymal cells in developing and adult rats with steroid-induced sterility. Steroids 67, 277-289. doi:10.1016/S0039-128X(01)00159-3
10. Byers, M., Kuiper, G. G., Gustafsson, J. A., and Park-Sarge, O. K. (1997). Estrogen receptor-β mRNA expression in rat ovary: down-regulation by gonadotropins. Mol. Endocrinol. 11, 172-182. doi:10.1210/ME.11.2.172
11. Chamson-Reig, A., Bianchi, M. S., Rey-Roldan, E., Sorianello, E., Libertun, C., and Lux-Lantos, V. (1999). Development of an experimental ovarian tumor over a year in the rat. Life Sci. 65, 1275-1285. doi:10.1016/S0024-3205(99)00363-X
12. Clark, B. J.,Wells, J., King, S. R., and Stocco,D. M. (1994).The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J. Biol. Chem. 269, 28 314-28 322.
13. Drummond, A. E., Britt, K. L., Dyson, M., Jones, M. E., Kerr, J. B., O'Donnell, L., Simpson, E. R., and Findlay, J. K. (2002). Ovarian steroid receptors and their role in ovarian function. Mol. Cell. Endocrinol. 191, 27-33. doi:10.1016/S0303-7207(02)00052-7
14. Dupont, E., Labrie, F., Luu-The, V., and Pelletier, G. (1992). Immunocytochemical localization of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human ovary. J. Clin. Endocrinol. Metab. 74, 994-998. doi:10.1210/JC.74.5.994
15. Esslimani-Sahla, M., Simony-Lafontaine, J., Kramar, A., Lavaill, R., Mollevi, C., Warner, M., Gustafsson, J. A., and Rochefort, H. (2004). Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer. Clin. Cancer Res. 10, 5769-5776. doi:10.1158/1078-0432.CCR-04-0389
16. Esslimani-Sahla, M., Kramar, A., Simony-Lafontaine, J., Warner, M., Gustafsson, J. A., and Rochefort, H. (2005). Increased estrogen receptor betacx expression during mammary carcinogenesis. Clin. Cancer Res. 11, 3170-3174. doi:10.1158/1078-0432.CCR-04-2298
17. Gilling-Smith, C., Willis, D. S., Beard, R. W., and Franks, S. (1994). Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J. Clin. Endocrinol. Metab. 79, 1158-1165. doi:10.1210/JC.79.4.1158
18. Gilling-Smith, C., Story, H., Rogers, V., and Franks, S. (1997). Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 47, 93-99. doi:10.1046/J.1365-2265.1997.2321049.X
19. Goodarzi, M. O., and Azziz, R. (2006). Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract. Res. Clin. Endocrinol. Metab. 20, 193-205. doi:10.1016/J.BEEM.2006.02.005
20. Green, J. A., and Goldzieher, J. W. (1965). The polycystic ovary. IV. Light and electron microscope studies. Am. J. Obstet. Gynecol. 91, 173-181.
21. Homburg, R. (2008). Polycystic ovary syndrome. Best Pract. Res. Clin. Obstet. Gynaecol. 22, 261-274. doi:10.1016/J.BPOBGYN.2007.07.009
22. Isobe, N., Nakao,T., andYoshimura,Y. (2003). Immunohistochemical localization of 3β-hydroxysteroid dehydrogenase in the granulosa and theca interna layers of bovine cystic follicles. J. Reprod. Dev. 49, 227-233. doi:10.1262/JRD.49.227
23. Jakimiuk,A. J.,Weitsman, S. R., Brzechffa, P. R., and Magoffin,D.A. (1998). Aromatase mRNA expression in individual follicles from polycystic ovaries. Mol. Hum. Reprod. 4, 1-8. doi:10.1093/MOLEHR/4.1.1
24. Jakimiuk, A. J., Weitsman, S. R., Navab, A., and Magoffin, D. A. (2001). Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J. Clin. Endocrinol. Metab. 86, 1318-1323. doi:10.1210/JC.86.3.1318
25. Jakimiuk, A. J., Weitsman, S. R., Yen, H. W., Bogusiewicz, M., and Magoffin, D. A. (2002). Estrogen receptor alpha and beta expression in theca and granulosa cells fromwomen with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87, 5532-5538. doi:10.1210/JC.2002-020323
26. Johannesson, U., Sahlin, L., Masironi, B., Hilliges, M., Blomgren, B., Rylander, E., and Bohm-Starke, N. (2008). Steroid receptor expression and morphology in provoked vestibulodynia. Am. J. Obstet. Gynecol. 198, 311.e1-311.e6. doi:10.1016/J.AJOG.2007.09.041
27. Juneau, C., Dupont, E., Luu-The,V., Labrie, F., and Pelletier,G. (1993). Ontogenesis of 3β-hydroxysteroid dehydrogenase/δ5-δ4-isomerase in the rat ovary as studied by immunocytochemistry and in situ hybridization. Biol. Reprod. 48, 226-234. doi:10.1095/ BIOLREPROD48.2.226
28. Kaaijk, E. M., Sasano, H., Suzuki,T., Beek, J. F., and van DerVeen, F. (2000). Distribution of steroidogenic enzymes involved in androgen synthesis in polycystic ovaries: an immunohistochemical study. Mol. Hum. Reprod. 6, 443-447. doi:10.1093/MOLEHR/6.5.443
29. Kafali, H., Iriadam, M., Osardah, I., and Demir,N. (2004). Letrozole-induced polycystic ovaries in the rat: a newmodel for cystic ovarian disease.Arch. Med. Res. 35, 103-108. doi:10.1016/J.ARCMED.2003.10. 005
30. Kahsar-Miller, M. D., Conway-Myers, B. A., Boots, L. R., and Azziz, R. (2001). Steroidogenic acute regulatory protein (StAR) in the ovaries of healthy women and those with polycystic ovary syndrome.Am. J. Obstet. Gynecol. 185, 1381-1387. doi:10.1067/MOB.2001.118656
31. Kiriakidou, M., McAllister, J. M., Sugawara, T., and Strauss, J. F., III (1996). Expression of steroidogenic acute regulatory protein (StAR) in the human ovary. J. Clin. Endocrinol. Metab. 81, 4122-4128. doi:10.1210/JC.81.11.4122
32. Korenman, S. G., Stevens, R. H., Carpenter, L. A., Robb, M., Niswender, G. D., and Sherman, B. M. (1974). Estradiol radioimmunoassay without chromatography: procedure, validation and normal values. J. Clin. Endocrinol. Metab. 38, 718-720.
33. Lejeune, M., Jaén, J., Pons, L., López, C., Salvadó, M. T., et al. (2008). Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: validation of a newcomputer-assisted image analysis procedure. J. Anat. 212, 868-878. doi:10.1111/J.1469-7580.2008.00910.X
34. Lin,D., Sugawara,T., Strauss, J. F., 3rd, Clark,B. J., Stocco,D. M., Saenger, P., Rogol, A., and Miller, W. L. (1995). Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267, 1828-1831. doi:10.1126/SCIENCE.7892608
35. Lydon, J. P., DeMayo, F. J., Funk, C. R., Mani, S. K., Hughes, A. R., Montgomery, C. A. Jr., Shyamala, G., Conneely, O. M., and O'Malley, B. W. (1995). Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9, 2266-2278. doi:10.1101/GAD.9.18.2266
36. Mahajan, D. K. (1988). Steroidogenesis in human polycystic ovary. Endocrinol. Metab. Clin. North Am. 17, 751-769.
37. Mannerås, L., Cajander, S., Holmang,A., Seleskovic, Z.,Lystig,T., Lonn, M., and Stener-Victorin, E. (2007). A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 148, 3781-3791. doi:10.1210/EN.2007-0168
38. Marcondes, F. K., Bianchi, F. J., and Tanno, A. P. (2002). Determination of the estrous cycle phases of rats: some helpful considerations. Braz. J. Biol. 62, 609-614. doi:10.1590/S1519-69842002000400008
39. Mason, J. I., Keeney, D. S., Bird, I. M., Rainey, W. E., Morohashi, K., Leers-Sucheta, S., and Melner, M. H. (1997). The regulation of 3beta-hydroxysteroid dehydrogenase expression. Steroids 62, 164-168. doi:10.1016/S0039-128X(96)00176-6
40. Matalliotakis, I., Kourtis, A., Koukoura, O., and Panidis, D. (2006). Polycystic ovary syndrome: etiology and pathogenesis. Arch. Gynecol. Obstet. 274, 187-197. doi:10.1007/S00404-006-0171-X
41. Meenakumari, K. J., Agarwal, S., Krishna, A., and Pandey, L. K. (2004). Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome. Braz. J. Med. Biol. Res. 37, 1637-1644. doi:10.1590/S0100-879X2004001100007
42. Morin-Papunen, L. C., Vauhkonen, I., Koivunen, R. M., Ruokonen, A., and Tapanainen, J. S. (2000). Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome. Hum. Reprod. 15, 1266-1274. doi:10.1093/HUMREP/15.6.1266
43. Nabi, G., Seth, A., Dinda, A. K., and Gupta, N. P. (2004). Computer-based receptogram approach: an objectiveway of assessing immunohistochemistry of androgen receptor staining and its correlation with hormonal response in metastatic carcinoma of prostate. J. Clin. Pathol. 57, 146-150. doi:10.1136/JCP.2003.010520
44. National Research Council (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press,Washington.
45. Nelson,V. L., Legro, R. S., and Strauss, J. F., 3rd, and McAllister, J.M. (1999). Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol. Endocrinol. 13, 946-957. doi:10.1210/ME.13.6.946
46. Nilsson, O., Chrysis, D., Pajulo, O., Boman, A., Holst, M., Rubinstein, J., Martin Ritzén, E., and Sávendahl, L. (2003). Localization of estrogen receptors-alpha and -beta and androgen receptor in the human growth plate at different pubertal stages. J. Endocrinol. 177, 319-326. doi:10.1677/JOE.0.1770319
47. Ortega, H. H., Salvetti, N. R., Müller, L. A., Amable, P., Lorente, J. A., Barbeito, C. G., and Gimeno, E. J. (2007). Characterization of cytoskeletal proteins in follicular structures of cows with cystic ovarian disease. J. Comp. Pathol. 136, 222-230. doi:10.1016/J.JCPA.2007. 02.001
48. Ortega, H. H., Salvetti, N. R., and Padmanabhan, V. (2009). Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance. Reproduction 137, 865-877. doi:10.1530/REP-08-0491
49. Pierro, E., Andreani, C. L., Lazzarin, N., Cento, R., Lanzone, A., Caruso, A., and Mancuso, S. (1997). Further evidence of increased aromatase activity in granulosa luteal cells from polycystic ovary. Hum. Reprod. 12, 1890-1896. doi:10.1093/HUMREP/12.9.1890
50. Readhead, C., Lobo, R. A., and Kletzky, O. A. (1983). The activity of 3beta-hydroxysteroid dehydrogenase and delta 4-5 isomerase in human follicular tissue. Am. J. Obstet. Gynecol. 145, 491-495.
51. Salvetti, N. R., Canal, A. M., Gimeno, E. J., and Ortega, H. H. (2004). Polycystic ovarian syndrome: temporal characterization of the induction and reversion process in an experimental model. Braz. J. Vet. Res. Anim. Sci. 41, 389-395. doi:10.1590/S1413-95962004000600006
52. Salvetti, N. R., Muller, L. A., Acosta, J. C., Gimeno, J. E., and Ortega, H. H. (2007). Estrogen receptors α and β and progesterone receptors in ovarian follicles of cows with cystic ovarian disease. Vet. Pathol. 44, 373-378. doi:10.1354/VP.44-3-373
53. Salvetti, N. R., Baravalle, C., Mira, G. A., Gimeno, E. J., Dallard, B. E., Rey, F., and Ortega, H. H. (2008). Heat shock protein 70 and sex steroid receptors in the follicular structures of induced ovarian cysts. Reprod. Domest. Anim. (Oct), 22 [Epub ahead of print].
54. Shan, L. X., Bardin, C. W., and Hardy, M. P. (1997). Immunohistochemical analysis of androgen effects on androgen receptor expression in developing Leydig and Sertoli cells. Endocrinology 138, 1259-1266. doi:10.1210/EN.138.3.1259
55. Sharangpani, G. M., Joshi, A. S., Porter, K., Deshpande, A. S., Keyhani, S., Naik, G. A., Gholap, A. S., and Barsky, S. H. (2007). Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer. J. Microsc. 226, 244-255. doi:10.1111/J.1365-2818.2007.01772.X
56. Sharma, S. C., Clemens, J. W., Pisarska, M. D., and Richards, J. S. (1999). Expression and function of estrogen receptor subtypes in granulosa cells: regulation by estradiol and forskolin. Endocrinology 140, 4320-4334. doi:10.1210/EN.140.9.4320
57. Silverman, E., Yivgi-Ohana, N., Sher, N., Bell, M., Eimerl, S., and Orly, J. (2006). Transcriptional activation of the steroidogenic acute regulatory protein (StAR) gene: GATA-4 and CCAAT/enhancer-binding protein beta confer synergistic responsiveness in hormone-treated rat granulosa and HEK293 cell models. Mol. Cell. Endocrinol. 252, 92-101. doi:10.1016/J.MCE. 2006.03.008
58. Stocco,D. M. (1997).The steroidogenic acute regulatory (StAR) protein two years later. An update. Endocrine 6, 99-109. doi:10.1007/ BF02738952
59. Svensson, E. C., Markstrom, E., Andersson, M., and Billig, H. (2000). Progesterone receptor-mediated inhibition of apoptosis in granulosa cells isolated from rats treated with human chorionic gonadotropin. Biol. Reprod. 63, 1457-1464. doi:10.1095/BIOLREPROD63.5.1457
60. Takayama, K., Fukaya, T., Sasano, H., Funayama,Y., Suzuki, T., Takaya, R., Wada,Y., andYajima,A. (1996). Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome. Hum. Reprod. 11, 1387-1392.
61. Teerds, K. J., and Dorrington, J. H. (1993). Immunohistochemical localization of 3-beta-hydroxysteroid dehydrogenase in the rat ovary during follicular development and atresia. Biol. Reprod. 49, 989-996. doi:10.1095/BIOLREPROD49.5.989
62. Tetsuka, M., and Hillier, S. G. (1997). Differential regulation of aromatase and androgen receptor in granulosa cells. J. Steroid Biochem. Mol. Biol. 61, 233-239. doi:10.1016/S0960-0760(97)80017-9
63. Thompson, W. E., Powell, J., Thomas, K. H., and Whittaker, J. A. (1999). Immunolocalization and expression of the steroidogenic acute regulatory protein during the transitional stages of rat follicular differentiation. J. Histochem. Cytochem. 47, 769-776.
64. Ullmann, S. L., Russell, A. J., Mason, J. I., and Selwood, L. (2003). Species differences in the ovarian distribution of 3beta-hydroxysteroid dehydrogenase/delta5→4 isomerase (3beta-HSD) in two marsupials: the brushtail possum (Trichosurus vulpecular) and the grey, shorttailed opossum (Monodelphis domestica). Reproduction 125, 65-73. doi:10.1530/REP.0.1250065
65. Wang, H., Masironi, B., Eriksson, H., and Sahlin, L. (1999). A comparative study of estrogen receptors a and β in the rat uterus. Biol. Reprod. 61, 955-964. doi:10.1095/BIOLREPROD61.4.955
66. Wang, H., Eriksson, H., and Sahlin, L. (2000). Estrogen receptors a and β in the female reproductive tract of the rat during the estrous cycle. Biol. Reprod. 63, 1331-1340. doi:10.1095/BIOLREPROD63.5.1331
67. Zhu, L. J., Hardy, M. P., Inigo, I. V., Huhtaniemi, I., Bardin, C. W., and Moo-Young, A. J. (2000). Effects of androgen on androgen receptor expression in rat testicular and epididymal cells: a quantitative immunohistochemical study. Biol. Reprod. 63, 368-376. doi:10.1095/BIOLREPROD63.2.368